Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Latest, FY2025
4,913
Period ended Dec 31, 2025
Change on a year earlier
+11.2%
4,420 in FY2024
History
18 years
Since FY2008
Sources
17
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Accounts receivable, net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,913 | +11.2% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 4,420 | -5.2% | Form 10-K (filed 2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 4,660 | -2.4% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 4,777 | +6.3% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 4,493 | -8.2% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 4,892 | +36.6% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 3,582 | +7.7% | Form 10-K (filed 2020-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 3,327 | -13.6% | Form 10-K (filed 2019-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 3,851 | -14.7% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 4,514 | -22.9% | Form 10-K (filed 2017-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 5,854 | +26.3% | Form 10-K (filed 2016-02-24) ↗ |
| FY2014 | Dec 31, 2014 | 4,635 | +112.4% | Form 10-K (filed 2015-02-25) ↗ |
| FY2013 | Dec 31, 2013 | 2,182 | +24.6% | Form 10-K (filed 2015-02-25) ↗ |
| FY2012 | Dec 31, 2012 | 1,751 | -10.2% | Form 10-K (filed 2013-02-27) ↗ |
| FY2011 | Dec 31, 2011 | 1,951 | +20.3% | Form 10-K (filed 2012-02-23) ↗ |
| FY2010 | Dec 31, 2010 | 1,622 | +16.7% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 1,390 | +35.8% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | 1,023 | – | Form 10-Q (filed 2009-08-05) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Accounts receivable, net ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_ar
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.